Pfizer to start shipping biosimilar version of J&J’s Remicade in November – Reuters

Pfizer to start shipping biosimilar version of J&J’s Remicade in November
Reuters
N) said on Monday it will begin shipping its biosimilar version of Johnson & Johnson’s (JNJ.N) blockbuster rheumatoid arthritis drug Remicade in late November at a 15 percent discount to current wholesale prices. The Pfizer drug, to be sold under the

and moreĀ >>

Source: shipping – Google News

Sharing information is key – Shipping Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd